Effectiveness of an Interactive Educational Website for Improving the Quality of Mental Health Care for People With Schizophrenia

This study has been completed.
Sponsor:
Information provided by:
National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier:
NCT00312949
First received: April 7, 2006
Last updated: February 29, 2008
Last verified: February 2008

April 7, 2006
February 29, 2008
April 2006
October 2007   (final data collection date for primary outcome measure)
Concordance of treatment with evidence-based recommendations [ Time Frame: Measured at Month 6 ] [ Designated as safety issue: No ]
Measured 6 months post-intervention: Concordance of treatment with evidence-based recommendations
Complete list of historical versions of study NCT00312949 on ClinicalTrials.gov Archive Site
  • Patient engagement in dialogue with clinician about schizophrenia management issues [ Time Frame: Measured at visit immediately following intervention/control condition ] [ Designated as safety issue: No ]
  • Clinician satisfaction with interaction with patient [ Time Frame: Measured at visit immediately following intervention/control condition ] [ Designated as safety issue: No ]
  • Patient satisfaction with interaction with clinician [ Time Frame: Measured at visit immediately following intervention/control condition and at Month 2 post-intervention ] [ Designated as safety issue: No ]
  • Symptoms of psychosis [ Time Frame: Measured at Month 2 post-intervention ] [ Designated as safety issue: No ]
  • Symptoms of depression [ Time Frame: Measured at Month 2 post-intervention ] [ Designated as safety issue: No ]
  • Quality of life ratings [ Time Frame: Measured at Month 2 post-intervention ] [ Designated as safety issue: No ]
  • Adherence to care regimen [ Time Frame: Measured at Month 2 post-intervention ] [ Designated as safety issue: No ]
  • Satisfaction with outcomes of care [ Time Frame: Measured at Month 2 post-intervention ] [ Designated as safety issue: No ]
  • Measured during study visit: Patient engagement in dialogue with clinician about schizophrenia management issues
  • Clinician satisfaction with interaction with patient
  • Measured during study visit and 2 months post-intervention: Patient satisfaction with interaction with clinician
  • Measured 2 months post-intervention: Symptoms of psychosis
  • Symptoms of depression
  • Quality of life ratings
  • Adherence to care regimen
  • Satisfaction with outcomes of care
Not Provided
Not Provided
 
Effectiveness of an Interactive Educational Website for Improving the Quality of Mental Health Care for People With Schizophrenia
Consumer Internet Education About Mental Health Quality

This study will evaluate the effectiveness of an interactive educational website in enhancing discussions about treatment issues and improving the quality of care for people with schizophrenia.

Schizophrenia is a disabling mental disorder that causes hallucinations and delusions in those affected by it. Research has proven that certain treatment methods are more effective in treating schizophrenia than others. However, not everyone with schizophrenia responds to treatment in the same way, and not all physicians use the same treatment methods. Educating individuals with schizophrenia about all treatments available instead of only the treatments they are receiving may improve the quality of care and lead to better correlation between treatment and quality standards. This study will evaluate the effectiveness of an interactive educational website in enhancing discussions about treatment issues and improving the congruence between expected quality of treatment and treatment received among people with schizophrenia.

Participants in this open label study will be randomly assigned to either use the interactive website or read written materials and watch a video. All three sources will contain information about evidence-based treatment recommendations. Both groups will complete a brief interview before performing their assigned tasks. Upon completion of the interview, participants in the written materials/video group will be given the reading material and will watch a 20-minute video. Participants in the web-user group will sit with a laptop computer, answer questions about themselves and their treatment, receive feedback on care that may be inconsistent with current recommendations, and receive suggestions on how to discuss this with their physicians. Participants in clinical settings will be asked to allow their next clinician visit to be audiotaped to assess outcomes. A phone interview will be conducted with all participants 2 months following the intervention to assess treatment satisfaction and other outcomes. Medical records will be reviewed to collect treatment information 6 months before and after the intervention.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Schizophrenia
  • Behavioral: Interactive Website on management of schizophrenia
    Participants in the web-user group will sit with a laptop computer, answer questions about themselves and their treatment, receive feedback on care that may be inconsistent with current recommendations, and receive suggestions on how to discuss this with their physicians.
  • Behavioral: Written materials and video on management of schizophrenia
    Participants in the written materials/video group will be given the reading material and will watch a 20-minute video.
  • Experimental: 1
    Participants will use the interactive website
    Intervention: Behavioral: Interactive Website on management of schizophrenia
  • Active Comparator: 2
    Participants will read written materials and watch a video
    Intervention: Behavioral: Written materials and video on management of schizophrenia
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
56
December 2007
October 2007   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diagnosis of schizophrenia
  • Able to read and write English
  • Scheduled to see a participating clinician at one of the study sites

Exclusion Criteria:

  • N/A
Both
13 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00312949
R01 MH67189, DSIR 82-SEDR
No
Donald M. Steinwachs, PhD, Johns Hopkins Bloomberg School of Public Health
National Institute of Mental Health (NIMH)
Not Provided
Principal Investigator: Donald M. Steinwachs, PhD Johns Hopkins Bloomberg School of Public Health
National Institute of Mental Health (NIMH)
February 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP